Skip to content
All Brands

Chiesi USA

2 recalls on record · Last recall: Aug 19, 2026

Read the history in context

Records, not a safety rating.

Recall counts do not account for sales volume, exposure or differences in reporting. Agency records can overlap. A low count does not establish that a brand or product is safe.

View source coverage →

Severity Breakdown

Class I — Serious
0
Class II — Moderate
1
Class III — Low Risk
1

Categories

MEDICATION

Recall Timeline

Class IIIFDAAug 19, 2026

Chiesi USA — Failed Stability Specifications: Out of specification stability result for the protein concentration profile.

Revcovi (elapegademase-lvlr) Injection, 2.4mg/1.5mL (1.6 mg/mL), Single-Dose Vial, Rx Only, For Intramuscular Use Only, Mfd. by Chiesi USA, Inc., Cary, NC 27518, NDC 10122-502-01 Failed Stability Specifications: Out of specification stability result for the protein concentration profile.

Class IIFDAJul 6, 2026

Chiesi USA — Lack of Assurance of Sterility

CLEVIPREX (clevidipine injectable emulsion) 50 mg/100 mL (0.5 mg/mL), 10 Single Use Vials, Rx Only, Manufactured for: Chiesi USA, Inc., Cary, NC 27518, by Fresenius Kabi, Graz, Austria, NDC 10122-611-10. Lack of Assurance of Sterility

Track Chiesi USA recalls automatically

Get an alert when a matching Chiesi USA recall turns up.

Start Free Trial